Alpha

Archives
Subscribe
March 9, 2026

Alpha Signal Monitor - Daily Market Briefing | March 09, 2026

Daily Market Research Report

March 09, 2026

Alpha Signal Monitor

Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.

Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts

Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM


This report is generated using advanced AI research capabilities with real-time market data access.


Institutional Outlook on Gold ETFs (GLD, IAU, BAR) — as of March 9, 2026

Trading Idea: Buy Rationale (TL;DR): Most top-tier houses remain constructive into 2026 on strong official-sector buying, the start of a Fed easing cycle, and returning ETF demand; price targets cluster around ~$4,800–$5,100/oz by late‑2026, implying further upside for physically backed ETFs like GLD, IAU, and BAR that track spot gold net of fees. (straitstimes.com)

Entering 2026, banks emphasize: 1) a Fed rate‑cutting cycle and softer real yields that historically support non‑yielding assets; 2) sustained central‑bank diversification and reserve accumulation; 3) sticky geopolitical and policy uncertainty; and 4) a potential drift weaker in the USD. Together, these underpin elevated gold prices and ETF inflows, though volatility is expected. (morganstanley.com)

Key Drivers - Official‑sector (central bank) demand remains structurally high and is expected to persist through 2026. (goldmansachs.com) - Fed easing and lower real yields reduce the opportunity cost of holding gold. (morganstanley.com) - Resilient/increasing ETF inflows as Western investment demand returns. (straitstimes.com) - Fiscal deficits and concerns over policy uncertainty/debasement keep hedging demand elevated. (jpmorgan.com)

Institution Stance Price View Key Evidence Last Update Source
Goldman Sachs Overweight/Bullish $4,900/oz target for December 2026 GS lifted its Dec‑2026 gold target to $4,900, citing strong Western ETF inflows and ongoing central‑bank buying; risks skewed to the upside. (straitstimes.com) 2025-10-07 (straitstimes.com)
Morgan Stanley Overweight/Bullish (Wealth Mgmt/Research) $4,400/oz for 2026 (revised up from ~$3,313) MS expects the rally to extend into 2026 on weaker USD, ETF inflows, and central‑bank demand; warns jewelry demand could soften. (morganstanley.com) 2025-10-22 (morganstanley.com)
JP Morgan Conviction Long/Bullish $5,055/oz by Q4 2026; longer‑term $6,000 by 2028 JPM sees gold as its highest‑conviction long into a Fed cutting cycle, with 4Q26 near ~$5,055 on robust investor and central‑bank demand. (mining.com) 2025-10-24 (mining.com)
Bank of America Bullish Upside to $5,000/oz in 2026; ~${4,400}/oz average BofA raised its 2026 outlook to as high as $5,000 (avg. around $4,400), flagging supportive macro drivers but acknowledging near‑term correction risk. (tradingview.com) 2025-10-13 (tradingview.com)
Citigroup Neutral/Hold (base case) with bullish upside scenario Base: grind lower from ~$4,200; Bull case: $5,000 by end‑2026 Citi’s December 2025 ‘Prospects for 2026’ note doesn’t see gold as a great bullish trade at ~$4,200; base case is a gradual drift lower, but bull case reaches $5,000 by end‑2026. (citigroup.com) 2025-12-08 (citigroup.com)
UBS Attractive/Long (CIO) $5,000/oz in 1H26; $4,800/oz by Dec‑2026 (raised from $4,300) UBS CIO expects continued demand from central banks and investors; projects sizeable 2026 ETF inflows and keeps gold at Attractive with a long bias. (ubs.com) 2026-01-30 (ubs.com)
HSBC Constructive but cautious (broad range) Peak risk up to ~$5,000 in H1‑2026; 2026 average guided around mid‑$4,000s with wide $3,600–$4,400+ range HSBC highlights elevated risks/fiscal deficits; expects prices to peak in H1‑2026 with a wide 2026 trading range and potential highs near $5,000. (uk.finance.yahoo.com) 2025-10-17 (peak scenario); 2025-10-??/2025-11‑?? range updates (uk.finance.yahoo.com)
Deutsche Bank Positive/Bullish 2026 average ~$4,450/oz; range ~$3,950–$4,950 DB raised its 2026 forecast to ~$4,450 with a ~$3,950–$4,950 range on persistent central‑bank demand and stabilizing investor flows. (investing.com) 2025-11-26 (investing.com)

Risk Considerations - Hawkish‑leaning Fed or a rebound in real yields/stronger USD could pressure gold and trigger ETF outflows. (morganstanley.com) - Central‑bank buying could slow or reverse; large ETF outflows would weigh on prices. (ubs.com) - Improving global growth/risk sentiment could rotate flows away from hedges toward risk assets. (citigroup.com) - Positioning is elevated; speculative long liquidation can cause sharp pullbacks. (goldmansachs.com)

For broad gold exposure, physically backed ETFs (GLD, IAU, BAR) should continue to track the institutional bullish base case; add on pullbacks and size positions for elevated volatility. Watch real yields/US dollar, central‑bank purchase data, and ETF flow momentum as near‑term gauges of trend durability. (morganstanley.com)


Stock Ratings — Street targets and ratings from GS/MS/JPM/BAC/C/WFC — as of March 9, 2026

Below is a structured, source‑linked rollup of the latest publicly reported targets/ratings from the six requested institutions for the specified U.S. large caps. Notes: Overweight/Buy are treated as positive ("Buy" equivalent), Equal‑Weight/Neutral as "Hold", Underweight as "Sell" for consensus mapping. Targets are shown in the currency quoted by the source; TSMC targets are in New Taiwan dollars (NT$).

AAPL - Apple Inc.

All six are positive on Apple; latest targets cluster in the low‑to‑mid $300s with an average near $318 and a Buy consensus. Highlights include Goldman Sachs at $330 (Buy), Morgan Stanley at $315 (Overweight), JPMorgan at $315 (Overweight), and BofA at $320 (Buy). (m.ng.investing.com)

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $330 2026-03-03 Reiterated on App Store momentum. https://m.ng.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-apple-stock-on-iphone-17e-pricing-93CH-5267542?ampMode=1
Morgan Stanley Overweight $315 January 2026 Part of MS 2026 North America IT hardware outlook. https://www.investing.com/news/stock-market-news/apple-price-target-raised-at-morgan-stanley-in-2026-it-hardware-outlook-4413024
JP Morgan Overweight $315 2026-01-26 Target raised from $305. https://www.marketbeat.com/instant-alerts/apple-nasdaqaapl-price-target-raised-to-31500-at-jpmorgan-chase-co-2026-01-26/
Bank of America Buy $320 2025-10-29 Raised from $270 ahead of FQ4’25; reiterated Buy. https://appleinsider.com/articles/25/10/29/bank-of-america-raises-apple-stock-target-to-320-betting-on-ai-the-smart-home
Citigroup Buy $330 2025-12-09 Raised from $315 on stronger IP17 cycle outlook. https://it.investing.com/news/stock-market-news/citi-alza-il-target-di-prezzo-di-apple-su-ciclo-di-aggiornamento-piu-solido-e-forza-delliphone-17-3131339
Wells Fargo Overweight $300 2025-12-29 OW reiterated on China share gains. https://www.investing.com/news/analyst-ratings/wells-fargo-maintains-overweight-rating-on-apple-stock-amid-china-gains-93CH-4423681

Consensus View - Rating: Buy, Target Price: $318.3 - 6/6 positive (Buy/OW).

MSFT - Microsoft Corp.

Consensus Buy with an average target around $608; recent 2026 updates include Morgan Stanley $650 (OW), JPMorgan $550 (OW), Wells Fargo $630 (OW), and Goldman Sachs $600 (Buy). (investing.com)

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $600 2026-01-29 Buy reiterated; prior target $655 earlier in Jan. https://www.marketbeat.com/instant-alerts/microsofts-msft-buy-rating-reiterated-at-the-goldman-sachs-group-2026-01-29/
Morgan Stanley Overweight $650 2026-01-14 OW and $650 PT reiterated following CIO survey. https://www.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-rating-on-microsoft-stock-at-650-93CH-4446158
JP Morgan Overweight $550 2026-01-29 Cut from $575 on valuation; OW maintained. https://m.ng.investing.com/news/analyst-ratings/microsoft-stock-price-target-lowered-to-550-by-jpmorgan-on-valuation-93CH-2312468?ampMode=1
Bank of America Buy $585 2025-07-18 Raised from $515 on Azure strength. https://www.investing.com/news/analyst-ratings/bofa-securities-raises-microsoft-stock-price-target-to-585-on-azure-strength-93CH-4142222
Citigroup Buy $635 2026-01-29 Cut from $660 post‑earnings; Buy maintained. https://www.marketbeat.com/instant-alerts/microsoft-nasdaqmsft-given-new-63500-price-target-at-citigroup-2026-01-29/
Wells Fargo Overweight $630 2026-01-22 Lowered from $665; OW maintained. https://www.marketbeat.com/instant-alerts/microsoft-nasdaqmsft-price-target-lowered-to-63000-at-wells-fargo-company-2026-01-22/

Consensus View - Rating: Buy, Target Price: $608.3 - 6/6 positive (Buy/OW).

GOOGL - Alphabet Inc.

Broadly positive skew; average target near $317 with BofA $370 (Buy), GS $375 (Buy), JPM $300 (OW), MS $270 (OW). Wells Fargo upgraded to Overweight with a $387 PT in February 2026. (ae.marketscreener.com)

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $375 2026-01-13 Raised from $330. https://www.gurufocus.com/news/4109066/googl-goldman-sachs-maintains-buy-rating-raises-price-target-googl-stock-news
Morgan Stanley Overweight $270 2025-10-02 OW maintained. https://www.nasdaq.com/articles/morgan-stanley-maintains-alphabet-goog-overweight-recommendation
JP Morgan Overweight $300 2025-10-27 Raised from $260 on AI strength. https://www.investing.com/news/analyst-ratings/jpmorgan-raises-alphabet-stock-price-target-to-300-on-ai-strength-93CH-4309660
Bank of America Buy $370 2026-01-13 Raised from $335; Buy reiterated. https://ae.marketscreener.com/news/bofa-securities-raises-alphabet-s-price-target-to-370-from-335-buy-rating-maintained-ce7e58dbd18ff725
Citigroup Buy $200 2025-04-25 Raised from $195; Buy maintained. https://www.investing.com/news/analyst-ratings/citi-lifts-alphabet-stock-price-target-to-200-from-195-93CH-4004104
Wells Fargo Overweight $387 2026-02-23 Upgraded from Equal‑Weight; target raised from $350 to $387. https://www.tipranks.com/news/time-to-get-more-constructive-says-wells-fargo-on-alphabet-stock-googl

Consensus View - Rating: Buy, Target Price: $317.0 - Positive skew (5x Buy/OW, 1x OW after WFC upgrade).

AMZN - Amazon.com Inc.

Unanimous Buy/Overweight; average target about $286. MS at $315 (OW), BofA at $303 (Buy), GS at $275 (Buy), WFC at $295 (OW). (buttondown.com)

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $275 2025-10-03 Raised from $240. https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-amazon-stock-price-target-to-275-on-aws-growth-outlook-93CH-4270016
Morgan Stanley Overweight $315 2025-10-31 Raised from $300; named Top Pick. https://www.investing.com/news/analyst-ratings/amazon-stock-price-target-raised-to-315-from-300-at-morgan-stanley-93CH-4322937
JP Morgan Overweight $255 2025-07-11 Raised from $240. https://www.gurufocus.com/news/2972940/jp-morgan-raises-price-target-for-amazon-amzn-to-255--amzn-stock-news
Bank of America Buy $303 2026-01-12 Buy reiterated on AI potential. https://www.investing.com/news/analyst-ratings/amazon-stock-rating-reiterated-at-buy-by-bofa-on-ai-potential-93CH-4440984
Citigroup Buy $273 2025-02-07 Maintained Buy on Alexa+/AI catalysts. https://www.investing.com/news/analyst-ratings/citi-maintains-buy-on-amazon-stock-targets-273-on-alexa-launch-3895355
Wells Fargo Overweight $295 2025-12-02 Raised from $292; OW maintained. https://www.investing.com/news/analyst-ratings/amazon-stock-price-target-raised-to-295-from-292-at-wells-fargo-93CH-4385725

Consensus View - Rating: Buy, Target Price: $286.0 - 6/6 positive (Buy/OW).

NVDA - NVIDIA Corp.

All six positive; average target near $254 with BofA $275 (Buy), Citi $270 (Buy), MS $250 (OW), GS $250 (Buy), WFC $265 (OW), JPM $215 (OW). (investing.com)

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $250 2025-11-20 Raised from $240 on AI outlook. https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-nvidia-stock-price-target-to-250-on-ai-outlook-93CH-4369369
Morgan Stanley Overweight $250 2025-12-01 Target adjusted; OW maintained. https://www.gurufocus.com/news/3228857/morgan-stanley-adjusts-nvidia-nvda-price-target-to-250-nvda-stock-news
JP Morgan Overweight $215 2025-09-04 Raised from $170. https://www.gurufocus.com/news/3094266/jp-morgan-maintains-nvidia-nvda-overweight-rating-with-215-price-target--nvda-stock-news
Bank of America Buy $275 2025-12-11 Buy reiterated; target maintained. https://www.investing.com/news/analyst-ratings/bofa-securities-reiterates-buy-rating-on-nvidia-stock-maintains-275-target-93CH-4402511
Citigroup Buy $270 2026-01-07 Reiterated post‑CES. https://www.investing.com/news/analyst-ratings/citi-reiterates-buy-rating-on-nvidia-stock-maintains-270-price-target-93CH-4435366
Wells Fargo Overweight $265 2025-11-14 Raised from $220; OW maintained. https://www.gurufocus.com/news/3209758/wells-fargo-raises-nvidia-nvda-price-target-to-265-nvda-stock-news

Consensus View - Rating: Buy, Target Price: $254.2 - 6/6 positive (Buy/OW).

META - Meta Platforms Inc.

Consensus Buy with an average target near $799. BofA leads at $885 (Buy), MS at $850 (OW), GS at $815 (Buy); JPM at $735 (OW); Citi at $753 (Buy); WFC $754 (OW). (investing.com)

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $815 2025-10-30 Trimmed from $870 amid investment cycle. https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-meta-stock-price-target-to-815-on-investment-cycle-93CH-4317852
Morgan Stanley Overweight $850 2025-07-31 Raised from $750 on AI growth. https://www.investing.com/news/analyst-ratings/morgan-stanley-raises-meta-platforms-stock-price-target-to-850-on-ai-growth-93CH-4162166
JP Morgan Overweight $735 2025-06-04 Raised from $675 on growth outlook. https://www.investing.com/news/analyst-ratings/jpmorgan-raises-meta-stock-price-target-citing-growth-potential-4079981
Bank of America Buy $885 2026-01-29 Raised from $810 post‑earnings. https://www.investing.com/news/analyst-ratings/meta-stock-price-target-raised-to-885-from-810-at-bofa-securities-93CH-4472310
Citigroup Buy $753 2025-01-28 Buy maintained. https://www.investing.com/news/analyst-ratings/citi-maintains-buy-on-meta-stock-with-753-price-target-3833767
Wells Fargo Overweight $754 2026-01-23 PT lowered from $795; OW maintained. https://www.gurufocus.com/news/8547466/meta-wells-fargo-lowers-price-target-maintains-overweight-rating-meta-stock-news

Consensus View - Rating: Buy, Target Price: $798.7 - 6/6 positive (Buy/OW).

TSLA - Tesla Inc.

Mixed views; consensus falls to Hold/Mixed with wide dispersion. Morgan Stanley is OW at $410, Goldman is Neutral at $395, BofA Neutral at $341; JPMorgan and Wells Fargo remain bearish at $115 and $125 (UW), respectively; Citi Neutral $180. Average target ~ $261. (buttondown.com)

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Neutral $395 2025-09-18 Raised from $300; Neutral maintained. https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-tesla-stock-price-target-to-395-on-growth-outlook-93CH-4243853
Morgan Stanley Overweight $410 2025-10-02 Top Pick/Overweight retained. https://factandforecast.com/forecasts-market-data/stocks/tesla-tsla-forecast-accuracy/
JP Morgan Underweight $115 2025-04-23 Cut from $120; UW maintained. https://www.tipranks.com/news/the-fly/tesla-price-target-lowered-to-115-from-120-at-jpmorgan-2
Bank of America Neutral $341 2025-07-22 Raised from $305; Neutral maintained. https://www.tipranks.com/news/the-fly/tesla-price-target-raised-to-341-from-305-at-bofa-thefly
Citigroup Neutral $180 2025-10-18 Lowered from $196; Neutral maintained. https://www.investing.com/news/stock-market-news/citi-cuts-tesla-stock-target-urges-investors-to-be-patient-3376598
Wells Fargo Underweight $125 2026-01-29 Lowered from $130; bearish on core auto fundamentals. https://www.marketbeat.com/instant-alerts/wells-fargo-company-has-lowered-expectations-for-tesla-nasdaqtsla-stock-price-2026-01-29/

Consensus View - Rating: Hold/Mixed, Target Price: $261.0 - Split views: 1x OW, 3x Neutral, 2x UW.

AVGO - Broadcom Inc.

Strong Buy/OW skew across all six; average target about $403. BofA sits at $500 (Buy), MS $443 (OW), WFC $430 (OW), GS $360 (Buy), JPM $400 (OW), Citi $285 (Buy). (investing.com)

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $360 2025-09-05 Reiterated Buy post results. https://www.investing.com/news/analyst-ratings/broadcom-stock-holds-buy-rating-at-goldman-sachs-on-ai-momentum-93CH-4226196
Morgan Stanley Overweight $443 2025-12-01 Raised from $409. https://www.gurufocus.com/news/3228852/morgan-stanley-raises-price-target-for-avgo-to-443-avgo-stock-news
JP Morgan Overweight $400 2025-09-05 Raised from $325. https://www.investing.com/news/analyst-ratings/jpmorgan-raises-broadcom-stock-price-target-to-400-from-325-93CH-4226521
Bank of America Buy $500 2025-12-12 Raised from $460; top pick. https://www.investing.com/news/analyst-ratings/broadcom-stock-price-target-raised-to-500-by-bofa-on-ai-growth-93CH-4405225
Citigroup Buy $285 2025-06-06 Raised from $276 on AI growth. https://www.investing.com/news/analyst-ratings/citi-raises-broadcom-stock-price-target-to-285-on-ai-growth-93CH-4084758
Wells Fargo Overweight $430 2026-01-15 Upgraded to Overweight; target raised. https://www.investing.com/news/analyst-ratings/wells-fargo-upgrades-broadcom-stock-rating-on-ai-growth-potential-93CH-4449457

Consensus View - Rating: Buy, Target Price: $403.0 - 6/6 positive (Buy/OW).

TSM - Taiwan Semiconductor Manufacturing Co. (ADR: TSM)

Across‑the‑board bullish into 2026 on AI demand; targets quoted for Taiwan‑listed shares in NT$. Average of available targets ≈ NT$1,939 with GS at NT$2,600 (Conviction Buy), JPM at NT$2,100 (OW), BofA at NT$2,360 (Buy), MS at NT$1,588 (OW), Citi at NT$1,050 (Buy). No recent WFC target found. (investing.com)

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Conviction Buy NT$2,600 2026-01-15 Raised from NT$2,330 on multi‑year AI engine. https://www.investing.com/news/analyst-ratings/tsmc-price-target-raised-to-nt2600-by-goldman-sachs-on-ai-growth-93CH-4450325
Morgan Stanley Overweight NT$1,588 2025-09-30 Street‑high at the time; reflects N3 demand and pricing power. https://www.investing.com/news/stock-market-news/tsmc-stock-target-raised-at-morgan-stanley-on-expected-earnings-beat-4263158
JP Morgan Overweight NT$2,100 2026-01-07 Raised from NT$1,700 on AI‑led growth. https://www.investing.com/news/analyst-ratings/jpmorgan-raises-tsmc-stock-price-target-to-nt2100-on-ai-growth-outlook-93CH-4434161
Bank of America Buy NT$2,360 2026-01-15 Raised from NT$2,150; Buy maintained. https://www.investing.com/news/analyst-ratings/tsmc-stock-price-target-raised-to-nt2360-by-bofa-on-tech-leadership-93CH-4450329
Citigroup Buy NT$1,050 2025-04-10 Trimmed earlier in 2025; Buy maintained. https://www.investing.com/news/analyst-ratings/citi-cuts-tsmc-stock-price-target-to-twd1050-keeps-buy-rating-3978424
Wells Fargo - - - No recent WFC coverage/target located for TSMC in public sources. -

Consensus View - Rating: Buy, Target Price: NT$1,939.6 - 5/5 positive among banks with published targets; currency NT$.

Highlights

  • Most bullish clusters: MSFT (~$608 avg), META (~$799), AVGO (~$403) — all 6/6 positive.
  • TSLA shows widest dispersion; consensus Hold/Mixed with bearish JPM/WFC underweights balancing MS overweight.
  • TSMC targets are quoted in NT$ (Taiwan listing). For ADR valuation, convert NT$ consensus using current FX if needed.
  • Dates reflect the latest public articles/notes; sell‑side client notes may update sooner behind paywalls.

Need this exported to CSV or augmented with additional brokers (e.g., UBS, Barclays, Jefferies, Evercore)? I can extend the table or add FX‑converted ADR equivalents for TSMC on request.


IPO Calendar

Timeframe: March 9, 2026 to April 9, 2026 (US equity markets)

The next 30 days feature a handful of scheduled and likely US listings: a large cross‑border tech/fintech IPO (PayPay) targeting mid‑March on Nasdaq, one confirmed direct listing (FreeCast) on March 10, and two smaller, terms‑filed candidates (Swarmer and Salspera) that may launch subject to market conditions and SEC effectiveness. Activity follows a busy February that saw multiple pricings across biotech and industrials, including Agomab Therapeutics (AGMB) and Medtronic’s diabetes unit MiniMed (MMED), which help set valuation and aftermarket benchmarks heading into March. Timing for several deals remains fluid given market volatility; expect week‑of announcements rather than long lead‑time schedules. (nasdaq.com)

FreeCast, Inc. (CAST)

  • Expected listing date: March 10, 2026 (rescheduled)
  • Shares offered: 19,780,000 Class A common shares registered for potential resale in connection with a Nasdaq direct listing; no primary capital raise.
  • Exchange: Nasdaq Global Market
  • Business summary: Streaming technology and media infrastructure company that aggregates free and paid streaming content through a unified TV guide/platform for consumers and offers enterprise distribution/monetization solutions for partners. (sec.gov)
  • Notes: This is a direct listing (not a traditional IPO). Company announced the Nasdaq trading date moved to March 10, 2026 from an earlier target; listing remains subject to customary approvals. (nasdaq.com)
  • Sources: SEC prospectus (Form 424B4) for FreeCast, Inc. (sec.gov), Nasdaq press release: FreeCast reschedules direct listing to March 10, 2026, Nasdaq press release: FreeCast registration declared effective / anticipated listing

PayPay Corporation (ADS) (PAYP (proposed))

  • Expected listing date: March 12, 2026 (expected/pricing window week of March 9)
  • Price range: $17–$20 per ADS
  • Shares offered: 54,987,214 ADS (size and allocation subject to change at pricing).
  • Exchange: Nasdaq Global Select Market
  • Lead underwriters: Goldman Sachs & Co. LLC, J.P. Morgan, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC
  • Business summary: Japan’s leading mobile payments platform (SoftBank Group subsidiary) expanding into a broader digital finance ecosystem (payments, card, bank, securities). Roadshow launched March 2 (US time). (about.paypay.ne.jp)
  • Notes: Company publicly filed an F‑1 on Feb 12, 2026 and set a $17–$20 range; multiple outlets indicate an around‑March 12 Nasdaq listing target, though TechCrunch reported potential geopolitical‑related timing risk. Final pricing/timing remain subject to market conditions and SEC effectiveness. (sec.gov)
  • Sources: SoftBank Corp. press release (Feb 13, 2026): PayPay F‑1 filing and joint bookrunners, PayPay Corp. press release (Mar 3, 2026): IPO roadshow launch (Nasdaq ‘PAYP’), Investing.com: PayPay files for IPO; $17–$20 range and 54,987,214 ADS, IPOX calendar: expected Mar 12, 2026 listing window

Swarmer, Inc. (SWMR (proposed))

  • Expected listing date: TBD (company on file; potential March window, subject to effectiveness)
  • Price range: $4–$6 per share (as filed)
  • Shares offered: 3,000,000 primary shares (+ 450,000 overallotment), per latest S‑1/A.
  • Exchange: Nasdaq Capital Market (applied)
  • Lead underwriters: Lucid Capital Markets (sole bookrunner)
  • Business summary: Early‑stage defense‑tech software developer focused on AI‑enabled autonomous swarm coordination and multi‑domain unmanned systems command/control; proceeds earmarked for product development and commercialization. (sec.gov)
  • Notes: Filed S‑1 (Feb 2, 2026) and S‑1/A (Feb 19, 2026). Prospectus flags going‑concern and listing‑approval risks; no definitive pricing date posted as of March 9, 2026. (sec.gov)
  • Sources: SEC S‑1 (and S‑1/A) for Swarmer, Inc. (sec.gov), Renaissance Capital news note on terms (Feb 19, 2026), Market/press mentions confirming Lucid Capital Markets as underwriter

Salspera, Inc. (TKVA (proposed))

  • Expected listing date: TBD (terms filed; near‑term launch possible)
  • Price range: $14–$16 per share
  • Shares offered: 5,700,000 shares (plus 30‑day underwriters’ option)
  • Exchange: Nasdaq (applied)
  • Lead underwriters: Kingswood Capital Partners (d/b/a Kingswood Capital Markets)
  • Business summary: Clinical‑stage immuno‑oncology company developing live biotherapeutics; lead program Saltikva (orally administered Salmonella‑IL2) targets metastatic pancreatic cancer with proceeds intended for late‑stage development. (renaissancecapital.com)
  • Notes: Filed S‑1 on Feb 2, 2026 and set terms on Feb 23, 2026; no pricing date posted as of March 9, 2026; timing subject to market conditions and SEC review. (renaissancecapital.com)
  • Sources: Renaissance Capital: Salspera sets terms for $85m IPO (Feb 23, 2026), SEC filing index for Salspera, Inc. (Form S‑1)

Calendar reflects the best available information as of Monday, March 9, 2026. IPOs frequently shift within days of launch; sizes, price ranges, and dates may change at pricing. Direct listings (e.g., FreeCast) are included for completeness but are not primary offerings. Always confirm the latest filings on EDGAR and issuer/underwriter announcements before making decisions.


Sources

  • Stock Ratings: https://ae.marketscreener.com/news/bofa-securities-raises-alphabet-s-price-target-to-370-from-335-buy-rating-maintained-ce7e58dbd18ff725, https://ae.marketscreener.com/news/bofa-securities-raises-alphabet-s-price-target-to-370-from-335-buy-rating-maintained-ce7e58dbd18ff725?utm_source=openai, https://appleinsider.com/articles/25/10/29/bank-of-america-raises-apple-stock-target-to-320-betting-on-ai-the-smart-home, https://buttondown.com/alpha/archive/alpha-signal-monitor-daily-market-briefing-4169/, https://factandforecast.com/forecasts-market-data/stocks/tesla-tsla-forecast-accuracy/, https://it.investing.com/news/stock-market-news/citi-alza-il-target-di-prezzo-di-apple-su-ciclo-di-aggiornamento-piu-solido-e-forza-delliphone-17-3131339, https://m.ng.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-apple-stock-on-iphone-17e-pricing-93CH-5267542?ampMode=1, https://m.ng.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-apple-stock-with-330-price-target-93CH-2321142?ampMode=1&utm_source=openai, https://m.ng.investing.com/news/analyst-ratings/microsoft-stock-price-target-lowered-to-550-by-jpmorgan-on-valuation-93CH-2312468?ampMode=1, https://www.gurufocus.com/news/2972940/jp-morgan-raises-price-target-for-amazon-amzn-to-255--amzn-stock-news, https://www.gurufocus.com/news/3094266/jp-morgan-maintains-nvidia-nvda-overweight-rating-with-215-price-target--nvda-stock-news, https://www.gurufocus.com/news/3209758/wells-fargo-raises-nvidia-nvda-price-target-to-265-nvda-stock-news, https://www.gurufocus.com/news/3228852/morgan-stanley-raises-price-target-for-avgo-to-443-avgo-stock-news, https://www.gurufocus.com/news/3228857/morgan-stanley-adjusts-nvidia-nvda-price-target-to-250-nvda-stock-news, https://www.gurufocus.com/news/4109066/googl-goldman-sachs-maintains-buy-rating-raises-price-target-googl-stock-news, https://www.gurufocus.com/news/8547466/meta-wells-fargo-lowers-price-target-maintains-overweight-rating-meta-stock-news, https://www.investing.com/news/analyst-ratings/amazon-stock-price-target-raised-to-295-from-292-at-wells-fargo-93CH-4385725, https://www.investing.com/news/analyst-ratings/amazon-stock-price-target-raised-to-315-from-300-at-morgan-stanley-93CH-4322937, https://www.investing.com/news/analyst-ratings/amazon-stock-rating-reiterated-at-buy-by-bofa-on-ai-potential-93CH-4440984, https://www.investing.com/news/analyst-ratings/bofa-securities-raises-microsoft-stock-price-target-to-585-on-azure-strength-93CH-4142222, https://www.investing.com/news/analyst-ratings/bofa-securities-reiterates-buy-rating-on-nvidia-stock-maintains-275-target-93CH-4402511, https://www.investing.com/news/analyst-ratings/broadcom-stock-holds-buy-rating-at-goldman-sachs-on-ai-momentum-93CH-4226196, https://www.investing.com/news/analyst-ratings/broadcom-stock-price-target-raised-to-500-by-bofa-on-ai-growth-93CH-4405225, https://www.investing.com/news/analyst-ratings/citi-cuts-tsmc-stock-price-target-to-twd1050-keeps-buy-rating-3978424, https://www.investing.com/news/analyst-ratings/citi-lifts-alphabet-stock-price-target-to-200-from-195-93CH-4004104, https://www.investing.com/news/analyst-ratings/citi-maintains-buy-on-amazon-stock-targets-273-on-alexa-launch-3895355, https://www.investing.com/news/analyst-ratings/citi-maintains-buy-on-meta-stock-with-753-price-target-3833767, https://www.investing.com/news/analyst-ratings/citi-raises-broadcom-stock-price-target-to-285-on-ai-growth-93CH-4084758, https://www.investing.com/news/analyst-ratings/citi-reiterates-buy-rating-on-nvidia-stock-maintains-270-price-target-93CH-4435366, https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-meta-stock-price-target-to-815-on-investment-cycle-93CH-4317852, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-amazon-stock-price-target-to-275-on-aws-growth-outlook-93CH-4270016, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-nvidia-stock-price-target-to-250-on-ai-outlook-93CH-4369369, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-tesla-stock-price-target-to-395-on-growth-outlook-93CH-4243853, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-alphabet-stock-price-target-to-300-on-ai-strength-93CH-4309660, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-broadcom-stock-price-target-to-400-from-325-93CH-4226521, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-meta-stock-price-target-citing-growth-potential-4079981, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-tsmc-stock-price-target-to-nt2100-on-ai-growth-outlook-93CH-4434161, https://www.investing.com/news/analyst-ratings/meta-stock-price-target-raised-to-885-from-810-at-bofa-securities-93CH-4472310, https://www.investing.com/news/analyst-ratings/morgan-stanley-raises-meta-platforms-stock-price-target-to-850-on-ai-growth-93CH-4162166, https://www.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-rating-on-microsoft-stock-at-650-93CH-4446158, https://www.investing.com/news/analyst-ratings/tsmc-price-target-raised-to-nt2600-by-goldman-sachs-on-ai-growth-93CH-4450325, https://www.investing.com/news/analyst-ratings/tsmc-stock-price-target-raised-to-nt2360-by-bofa-on-tech-leadership-93CH-4450329, https://www.investing.com/news/analyst-ratings/wells-fargo-maintains-overweight-rating-on-apple-stock-amid-china-gains-93CH-4423681, https://www.investing.com/news/analyst-ratings/wells-fargo-upgrades-broadcom-stock-rating-on-ai-growth-potential-93CH-4449457, https://www.investing.com/news/stock-market-news/apple-price-target-raised-at-morgan-stanley-in-2026-it-hardware-outlook-4413024, https://www.investing.com/news/stock-market-news/citi-cuts-tesla-stock-target-urges-investors-to-be-patient-3376598, https://www.investing.com/news/stock-market-news/tsmc-stock-target-raised-at-morgan-stanley-on-expected-earnings-beat-4263158, https://www.marketbeat.com/instant-alerts/apple-nasdaqaapl-price-target-raised-to-31500-at-jpmorgan-chase-co-2026-01-26/, https://www.marketbeat.com/instant-alerts/microsoft-nasdaqmsft-given-new-63500-price-target-at-citigroup-2026-01-29/, https://www.marketbeat.com/instant-alerts/microsoft-nasdaqmsft-price-target-lowered-to-63000-at-wells-fargo-company-2026-01-22/, https://www.marketbeat.com/instant-alerts/microsofts-msft-buy-rating-reiterated-at-the-goldman-sachs-group-2026-01-29/, https://www.marketbeat.com/instant-alerts/wells-fargo-company-has-lowered-expectations-for-tesla-nasdaqtsla-stock-price-2026-01-29/, https://www.nasdaq.com/articles/morgan-stanley-maintains-alphabet-goog-overweight-recommendation, https://www.tipranks.com/news/the-fly/tesla-price-target-lowered-to-115-from-120-at-jpmorgan-2, https://www.tipranks.com/news/the-fly/tesla-price-target-raised-to-341-from-305-at-bofa-thefly, https://www.tipranks.com/news/time-to-get-more-constructive-says-wells-fargo-on-alphabet-stock-googl
  • IPO Calendar: https://about.paypay.ne.jp/en/pr/20260303/01/?utm_source=openai, https://www.nasdaq.com/press-release/agomab-announces-pricing-initial-public-offering-2026-02-06?utm_source=openai, https://www.nasdaq.com/press-release/freecast-inc-nasdaq-cast-announces-rescheduling-direct-listing-march-10-2026-2026-02?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/117206/Immuno-oncology-biotech-Salspera-sets-terms-for-%2485-million-IPO?utm_source=openai, https://www.sec.gov/Archives/edgar/data/1633369/000121390026023677/ea0279992-424b4_freecast.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2080845/000119312526047933/d941409df1.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2092574/000110465926009198/tm2529424-6_s1.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2092574/000110465926017547/0001104659-26-017547-index.html?utm_source=openai

Disclaimer

This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.

Generated on: 2026-03-09 at 11:42 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.


Powered by Alpha Signal Monitor | Market Intelligence Through AI

Don't miss what's next. Subscribe to Alpha:
Powered by Buttondown, the easiest way to start and grow your newsletter.